Colgate-Palmolive India Share Price in Focus; Reports 6.1% Sequential Sales Growth in Q2 FY26 Results

Colgate-Palmolive (India) Limited announced its financial results for the second quarter ended September 30, 2025. The company reported net sales of ₹1,507 crore, compared to ₹1,609 crore in the same period last year. On a sequential basis, sales rose by 6.1% from ₹1,421 crore in the previous quarter ended June 2025, indicating a steady recovery in demand.

Profit Decline Due to One-Time Base Impact

Net profit after tax for the quarter stood at ₹328 crore, down from ₹395 crore in Q2 FY25. The company noted that the decline in profit was primarily due to the one-time impact of interest on a tax refund recorded in the base year. Excluding this factor, profit declined by 7.2% year-on-year, reflecting continued investment in marketing and product innovation.

Interim Dividend Announcement

The Board of Directors declared a first interim dividend of ₹24 per equity share of face value of Re. 1 each for FY26. The total payout to shareholders amounts to ₹652.8 crore. The dividend will be paid on and from November 19, 2025, to shareholders whose names appear in the company’s records as of November 3, 2025.

Ms. Prabha Narasimhan, Managing Director & CEO of Colgate-Palmolive (India) Limited, said, “While we continued to navigate through a difficult operating environment, our second quarter performance also reflects the transitory disruption at distributors and retailers across channels caused by GST rate revision. Our first half performance cycles a high base of double digit net sales growth in the base period and we expect a gradual recovery in performance in the second half.”

Colgate-Palmolive (India) Share Price Performance

On October 24, 2025, Colgate-Palmolive (India) share price (NSE: COLPAL) opened at ₹2,245.00, down from its previous close of ₹2,286.90. At 9:57 AM, the share price of Colgate-Palmolive (India) was trading at ₹2,213.40, down by 3.21% on the NSE.

Also Read: Cipla’s New Move in Diabetes Segment with Eli Lilly’s Tirzepatide Launch!

Conclusion

Colgate-Palmolive India’s Q2 FY26 results reflect resilient performance despite a year-on-year dip in profit. The dividend declaration underscores the company’s strong cash position and commitment to shareholder value.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.